Methods and compositions associated with the granulocyte colony-stimulating factor receptor

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9492430
APP PUB NO 20140296292A1
SERIAL NO

14357551

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Some embodiments include compositions and methods of using or identifying compounds that modulate the activity of the granulocyte colony-stimulating factor receptor (GCFR). Some embodiments include use of compounds to treat certain disorders, such as hematopoietic or neurological disorders.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
LIGAND PHARMACEUTICALS INCORPORATED3911 SORRENTO VALLEY BOULEVARD SUITE 110 SAN DIEGO CA 92121

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Grant, Virginia H San Diego, US 4 2
Hudson, Andrew R San Diego, US 14 32
Marschke, Keith San Diego, US 4 2
Pedram, Bijan San Diego, US 23 154
Pickens, Jason C San Diego, US 14 76
Roach, Steven L San Diego, US 8 33
Shen, Yixing Encinitas, US 17 114
Valdez, Lino J San Diego, US 7 23
van, Oeveren C Arjan San Diego, US 1 2
Zhi, Lin San Diego, US 154 3068

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 May 15, 2028
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00